litlas
ログインアカウント作成

Nabil F. Saba

1999–2025 年に発表

別表記
Nabil F Saba
158
論文数
17,967
被引用数
58
h 指数
147
i10 指数

被引用数

Nabil F. Saba の年別被引用数1995 年: 被引用 1 件2000 年: 被引用 1 件2002 年: 被引用 3 件2004 年: 被引用 3 件2005 年: 被引用 1 件2006 年: 被引用 2 件2007 年: 被引用 6 件2008 年: 被引用 4 件2010 年: 被引用 3 件2011 年: 被引用 4 件2012 年: 被引用 5 件2013 年: 被引用 16 件2014 年: 被引用 8 件2015 年: 被引用 10 件2016 年: 被引用 14 件2017 年: 被引用 143 件2018 年: 被引用 198 件2019 年: 被引用 722 件2020 年: 被引用 856 件2021 年: 被引用 953 件2022 年: 被引用 876 件2023 年: 被引用 703 件2024 年: 被引用 1,213 件2025 年: 被引用 650 件2026 年: 被引用 29 件1996〜1999 年は被引用が無いため表示していません2001 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,860 件、この内訳の 23.6%中国: 引用元論文 1,485 件、この内訳の 18.8%イタリア: 引用元論文 384 件、この内訳の 4.9%日本: 引用元論文 352 件、この内訳の 4.5%ドイツ: 引用元論文 345 件、この内訳の 4.4%イギリス: 引用元論文 318 件、この内訳の 4%フランス: 引用元論文 290 件、この内訳の 3.7%カナダ: 引用元論文 228 件、この内訳の 2.9%スペイン: 引用元論文 212 件、この内訳の 2.7%オランダ: 引用元論文 188 件、この内訳の 2.4%オーストラリア: 引用元論文 185 件、この内訳の 2.3%インド: 引用元論文 176 件、この内訳の 2.2%
0%23.6%その他 23.6%

機関

分野

  • Medicine70.2%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Immunology and Microbiology6.6%
  • Engineering1.3%
  • Computer Science0.7%
  • Dentistry0.6%
  • その他2%

トピック

  • Cancer Immunotherapy and Biomarkers13.3%
  • Head and Neck Cancer Studies9.2%
  • Immunotherapy and Immune Responses4%
  • Immune Cell Function and Interaction2.7%
  • CAR-T cell therapy research2.7%
  • Esophageal Cancer Research and Treatment2.1%
  • その他66%

共著者

全論文

検索で開く
  1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 被引用: 5,078

  2. Head and neck cancer

    著者: Mayur D. Mody, James W. Rocco, Sue S. Yom, Robert I. Haddad, Nabil F. Saba - The Lancet 2021 被引用: 822

  3. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer

    著者: Christiane S. Eberhardt, Haydn Kissick, Mihir R. Patel, Maria A. Cardenas, Nataliya Prokhnevska, Rebecca C. Obeng, Tahseen H. Nasti, Christopher C. Griffith, Se Jin Im, Xu Wang, Dong M. Shin, Mary Carrington, Zhuo G. Chen, John Sidney, Alessandro Sette, Nabil F. Saba, Andreas Wieland, Rafi Ahmed - Nature 2021 被引用: 348

  4. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

    著者: Robert L. Ferris, Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J. Garcia, Christine H. Chung, Maura L. Gillison, Umamaheswar Duvvuri, Bert W. O'Malley, Enver Ozer, Giovana R. Thomas, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Nabil F. Saba, Miriam Lango, Eduardo Méndez, Barbara Burtness - Journal of Clinical Oncology 2021 被引用: 441

  5. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

    著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 被引用: 800

  6. Defining HPV-specific B cell responses in patients with head and neck cancer

    著者: Andreas Wieland, Mihir R. Patel, Maria A. Cardenas, Christiane S. Eberhardt, William Henry Hudson, Rebecca C. Obeng, Christopher Griffith, Xu Wang, Zhuo G. Chen, Haydn Kissick, Nabil F. Saba, Rafi Ahmed - Nature 2020 被引用: 229

  7. Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

    著者: Robert I. Haddad, Kevin J. Harrington, Makoto Tahara, Robert L. Ferris, Maura L. Gillison, Jérôme Fayette, Amaury Daste, P. Koralewski, Bogdan Żurawski, Miren Taberna, Nabil F. Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Ángel Álvarez-Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller‐Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Wei Li, Athanassios Argiris - Journal of Clinical Oncology 2022 被引用: 158

  8. An update on larynx cancer

    著者: Conor Steuer, Mark W. El‐Deiry, Jason R. Parks, Kristin Higgins, Nabil F. Saba - CA A Cancer Journal for Clinicians 2016 被引用: 697

  9. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

    著者: Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad - Journal of Clinical Oncology 2017 被引用: 652

  10. Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations

    著者: Alan L. Ho, Irene Braña, Robert I. Haddad, Jessica R. Bauman, Keith C. Bible, Sjoukje F. Oosting, Deborah Jean Lee Wong, Myung‐Ju Ahn, Valentina Boni, Caroline Even, Jérôme Fayette, M.J. Flor, Kevin J. Harrington, David S. Hong, Sung‐Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis P. Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto - Journal of Clinical Oncology 2021 被引用: 196

  11. Cancer metabolism and carcinogenesis

    著者: Jianqiang Yang, Chloe Shay, Nabil F. Saba, Yong Teng - Experimental Hematology and Oncology 2024 被引用: 120

  12. Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models

    著者: Vikash Kansal, Andre J. Burnham, Brendan L. C. Kinney, Nabil F. Saba, Chrystal M. Paulos, Gregory B. Lesinski, Zachary S. Buchwald, Nicole C. Schmitt - Journal for ImmunoTherapy of Cancer 2023 被引用: 98

  13. Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

    著者: Lillian L. Siu, Caroline Even, Ricard Mesı́a, Éva Remenár, Amaury Daste, Jean‐Pierre Delord, Jürgen Krauß, Nabil F. Saba, Lisle M. Nabell, Neal Ready, Irene Braña, Nuria Kotecki, Dan P. Zandberg, Jill Gilbert, Hisham Mehanna, Marcelo Bonomi, Anthony Jarkowski, Giovanni Melillo, J. Armstrong, Sophie Wildsmith, Jérôme Fayette - JAMA Oncology 2018 被引用: 310

  14. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

    著者: Nabil F. Saba, Conor Steuer, Asari Ekpenyong, Ashley A. McCook‐Veal, Kelly R. Magliocca, Mihir R. Patel, Nicole C. Schmitt, William A. Stokes, James E. Bates, Soumon Rudra, Jill Remick, Mark W. McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z. Chen, Dong M. Shin, Yong Teng, Christine H. Chung - Nature Medicine 2023 被引用: 76

  15. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline

    著者: Emrullah Yilmaz, Nofisat Ismaila, Julie E. Bauman, Raetasha Dabney, Gregory N. Gan, Richard C. Jordan, Marnie Kaufman, Kedar Kirtane, Sean M. McBride, Matthew Old, Lisa M. Rooper, Nabil F. Saba, Siddharth Sheth, Rathan M. Subramaniam, Trisha M. Wise‐Draper, Deborah J. Wong, Loren K. Mell - Journal of Clinical Oncology 2022 被引用: 96

  16. Artificial Intelligence in Head and Neck Cancer: A Systematic Review of Systematic Reviews

    著者: Antti Mäkitie, Rasheed Omobolaji Alabi, Sweet Ping Ng, Robert P. Takes, K. Thomas Robbins, Ohad Ronen, Ashok R. Shaha, Patrick J. Bradley, Nabil F. Saba, Sandra Nuyts, Asterios Triantafyllou, Cesare Piazza, Alessandra Rinaldo, Alfio Ferlito - Advances in Therapy 2023 被引用: 69

  17. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    著者: Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, A. Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E. Vokes, Francis P. Worden, Nabil F. Saba, Naomi Kiyota, Robert I. Haddad, Makoto Tahara, Viktor Grünwald, James W. Shaw, Manish Monga, Mark Lynch, Fiona Taylor, Michael DeRosa, L Morrissey, Kim Cocks, Maura L. Gillison, J. Guigay - The Lancet Oncology 2017 被引用: 430

  18. Management of locally recurrent nasopharyngeal carcinoma

    著者: Anne W.M. Lee, Wai Tong Ng, Jimmy Yu Wai Chan, June Corry, Antti Mäkitie, William M. Mendenhall, Alessandra Rinaldo, Juan P. Rodrigo, Nabil F. Saba, Primož Strojan, Carlos Suárez, Jan B. Vermorken, Sue S. Yom, Alfio Ferlito - Cancer Treatment Reviews 2019 被引用: 392

  19. Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck

    著者: Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz, Robert I. Haddad, Ammar Sukari, Prakash Neupane, John C. Morris, Krzysztof Misiukiewicz, Julie E. Bauman, Moon J. Fenton, Antonio Jimeno, Douglas R. Adkins, Charles Schneider, Assuntina G. Sacco, Keisuke Shirai, Daniel W. Bowles, Michael K. Gibson, T. Nwizu, Raphaël Gottardo, Kristi L. Manjarrez, Gregory N. Dietsch, James Kyle Bryan, Robert M. Hershberg, Ezra E.W. Cohen - JAMA Oncology 2018 被引用: 111

  20. Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

    著者: Christine H. Chung, Jiannong Li, Conor E. Steuer, Priyanka Bhateja, Matthew Johnson, Jude Masannat, Maria I. Poole, Feifei Song, Juan C. Hernandez-Prera, Helen Molina, Bruce M. Wenig, Sunil Kumar, Charlotte Kuperwasser, Philip J. Stephens, Joaquim M. Farinhas, Dong M. Shin, Julie A. Kish, Jameel Muzaffar, Kedar Kirtane, James W. Rocco, Michael J. Schell, Nabil F. Saba, Marcelo Bonomi - Clinical Cancer Research 2022 被引用: 86

  21. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

    著者: Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, Shethal Bearelly, Audrey Z. Baker, Conor Steuer, Anshu Giri, Barbara Burtness, Sara Centuori, Carlos Caulı́n, Robert J. Klein, Kathylynn Saboda, Stefanie Obara, Christine H. Chung - Journal of Clinical Oncology 2023 被引用: 48

  22. An update on the immune landscape in lung and head and neck cancers

    著者: Jennifer W. Carlisle, Conor Steuer, Taofeek K. Owonikoko, Nabil F. Saba - CA A Cancer Journal for Clinicians 2020 被引用: 153

  23. Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

    著者: Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T. Esser, Lily Cheng, Sonia Agrawal, Emily C. Jennings, Nicholas M. Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gascó Hernández, Rakesh Kumar - Clinical Cancer Research 2022 被引用: 47

  24. Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis

    著者: Ted Mau, Milan R. Amin, Peter C. Belafsky, Simon R. Best, Aaron D. Friedman, Adam M. Klein, David G. Lott, Randal C. Paniello, Seth M. Pransky, Nabil F. Saba, Tamara Howard, Michael Dallas, Aditya Patel, Matthew P. Morrow, Jeffrey M. Skolnik - The Laryngoscope 2023 被引用: 35